Exagen DSO Ratio 2011-2026 | XGN

Annual DSO Ratio Exagen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
51.2	47.2	43.9	63	70.1	77.5	51.6	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
77.5	43.9	57.8

Quarterly DSO Ratio Exagen

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
67.1	76.9	66.4	-	76.9	68.5	55.2	-	113	82.4	62.5	-	60	118	90.3	-	67	60.7	73.8	-	-	90.9	69.6	-	50	49.8	57.5	-	33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
118	33	70.9

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Bioventus BVS	82.1	$ 8.9	0.39 %	$ 593 M	USA
Castle Biosciences CSTL	49.2	$ 26.04	0.81 %	$ 723 M	USA
Aspira Women's Health AWH	50.7	-	-6.19 %	$ 10.5 M	USA
DexCom DXCM	87	$ 68.33	2.99 %	$ 26.7 B	USA
Guardant Health GH	46.1	$ 87.63	0.52 %	$ 11 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Charles River Laboratories International CRL	65	$ 154.73	1.82 %	$ 7.67 B	USA
CareDx, Inc CDNA	51.5	$ 17.59	1.56 %	$ 937 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
IQVIA Holdings IQV	73.9	$ 168.86	2.41 %	$ 29 B	USA
Exact Sciences Corporation EXAS	30.8	$ 103.89	0.04 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	77.4	$ 15.62	4.45 %	$ 472 M	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Biodesix BDSX	41.7	$ 16.88	-2.37 %	$ 2.19 B	USA
ICON Public Limited Company ICLR	68.5	$ 100.35	2.81 %	$ 8.28 B	Irlanda
Anixa Biosciences ANIX	275	$ 2.9	2.11 %	$ 94.1 K	USA
Danaher Corporation DHR	55.3	$ 195.77	2.29 %	$ 140 B	USA
NeoGenomics NEO	77.7	$ 8.36	1.46 %	$ 1.07 B	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Pacific Biosciences of California PACB	71.8	$ 1.4	2.95 %	$ 420 M	USA
Illumina ILMN	61.3	$ 121.89	2.18 %	$ 19.4 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 198.82	-0.06 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Agilent Technologies A	63.8	$ 113.9	1.85 %	$ 34.6 B	USA
BioNano Genomics BNGO	83.4	$ 1.12	0.9 %	$ 1.42 M	USA
DarioHealth Corp. DRIO	85.8	$ 9.28	10.24 %	$ 263 M	Israel
Neogen Corporation NEOG	66.6	$ 9.32	2.25 %	$ 2.02 B	USA
Lantheus Holdings LNTH	80.5	$ 78.96	0.59 %	$ 5.33 B	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	101	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	50.4	$ 452.34	-0.29 %	$ 13 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	66.4	$ 1 219.76	1.76 %	$ 25.1 B	Schweiz
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Twist Bioscience Corporation TWST	44.5	$ 46.61	3.55 %	$ 2.79 B	USA
National Research Corporation NRC	29.4	$ 18.05	3.71 %	$ 404 M	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 199.84	1.09 %	$ 19.7 B	USA